Pfizer Promoting Tiered Drug Coverage Policy For Middle-Income Nations
This article was originally published in PharmAsia News
Executive Summary
Pfizer is advocating a new U.S. trade stance toward setting parameters around foreign governments' drug reimbursement policies in middle-income nations
You may also be interested in...
South Korea Govt. Proposes “Refund System” To Give Multinational Pharmas Access To Patients At The Price They Want
Companies would “donate” difference between their price and the Ministry for Health, Welfare and Family Affairs’ preferred price to the government.
South Korea Govt. Proposes “Refund System” To Give Multinational Pharmas Access To Patients At The Price They Want
Companies would “donate” difference between their price and the Ministry for Health, Welfare and Family Affairs’ preferred price to the government.
South Korea Govt Proposes “Refund System” To Keep MNC Drug Prices Up, Provide Access To Patients
SEOUL - South Korea's Ministry for Health, Welfare and Family Affairs is in pursuit of what it calls a "refunding system" under which multinational companies could sell their products at prices they want under the coverage of the local National Health Insurance System